Close

Analyst Ratings for Recursion Pharmaceuticals (RXRX)

RXRX Rating Summary

RXRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on RXRX
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $17.60 (+73.1%) * Over Last 12-Mos
Rating Score: 3.3 / 10   Percentile Rank: 30%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/26/2024 TD Cowen Steven Mah New Coverage Hold
(N/A)
N/A
(N/A)
10.23
(10.17)
-0.59% Details
5/22/2023 Morgan Stanley
» Updated 7/13/2023
Vikram Purohit New Coverage Equalweight
(N/A)
11.00
(8.00)
5.47
(10.17)
85.92% Details
Like RXRX Ratings? Also take a look at NVDA, NNOX, SOUN

RXRX Ratings News